Overview

Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)

Status:
Unknown status

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

This study is designed to evaluate the efficacy of intravitreal Ranibizumab in comparison with macular laser photocoagulation as treatments for macular edema secondary to branch retinal vein occlusion. Characteristics of this study is as below 1. Multicenter, randomized clinical trial. (intravitreal Ranibizumab 0.5mg injection vs. macular laser photocoagulation) 2. After 48 weeks follow up, functional change(visual acuity)and anatomical change (central retinal thickness) would be evaluated

Phase:

Phase 3

Details

Lead Sponsor:

Seoul Retina Investigator Group

Collaborators:

Kyungpook National University
Kyungpook National University Hospital
Samsung Medical Center

Treatments:

Ranibizumab